Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study

NCT ID: NCT07619391Sponsor: Ohio State University Comprehensive Cancer CenterLast updated: 2026-06-02

Summary

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Detailed description

PRIMARY OBJECTIVE: I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment. OUTLINE: Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.

Arms & interventions

  • OtherElectronic Health Record Review

    Ancillary studies

  • BehavioralSmartphone Application-based Intervention

    Receive access to MyCap application

  • OtherSurvey Administration

    Ancillary studies

Outcome measures

Primary

  • Retention rate (feasibility)

    Defined as the number of participants who enroll in the study and complete at least one time log during the study period.

    Time frame: Up to 8 weeks

  • Adherence rate (feasibility)

    Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs.

    Time frame: Up to 8 weeks

  • System usability survey (feasibility)

    Time frame: Up to 8 weeks

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Adults ≥ 18 years old * Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days * English speaking * Access to a smartphone (Android or iOS) Exclusion Criteria: * Prisoners * Patients undergoing cancer surveillance

Study locations (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210

Recruiting
Pamela W. Lu, MD · Contact
614-293-7171Pamela.lu@osumc.edu
Pamela W. Lu, MD · Principal Investigator